HomeComparePRXEX vs JNJ

PRXEX vs JNJ: Dividend Comparison 2026

PRXEX yields 4.56% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PRXEX wins by $6.9K in total portfolio value
10 years
PRXEX
PRXEX
● Live price
4.56%
Share price
$7.92
Annual div
$0.36
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.9K
Annual income
$609.90
Full PRXEX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PRXEX vs JNJ

📍 PRXEX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPRXEXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PRXEX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PRXEX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PRXEX
Annual income on $10K today (after 15% tax)
$387.19/yr
After 10yr DRIP, annual income (after tax)
$518.42/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $185.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PRXEX + JNJ for your $10,000?

PRXEX: 50%JNJ: 50%
100% JNJ50/50100% PRXEX
Portfolio after 10yr
$23.5K
Annual income
$718.84/yr
Blended yield
3.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PRXEX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PRXEX buys
0
JNJ buys
0
No recent congressional trades found for PRXEX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPRXEXJNJ
Forward yield4.56%3.36%
Annual dividend / share$0.36$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$26.9K$20.0K
Annual income after 10y$609.90$827.78
Total dividends collected$5.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PRXEX vs JNJ ($10,000, DRIP)

YearPRXEX PortfolioPRXEX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,156$455.52$10,676$355.77+$480.00PRXEX
2$12,411$474.91$11,407$389.39+$1.0KPRXEX
3$13,774$493.80$12,198$426.53+$1.6KPRXEX
4$15,250$512.17$13,056$467.62+$2.2KPRXEX
5$16,848$529.96$13,987$513.12+$2.9KPRXEX
6$18,574$547.18$14,998$563.56+$3.6KPRXEX
7$20,438$563.79$16,098$619.52+$4.3KPRXEX
8$22,449$579.78$17,295$681.69+$5.2KPRXEX
9$24,615$595.15$18,599$750.82+$6.0KPRXEX
10$26,948$609.90$20,022$827.78+$6.9KPRXEX

PRXEX vs JNJ: Complete Analysis 2026

PRXEXStock

The fund will invest at least 80% of its net assets in income-producing securities, which may include, but are not limited to, U.S. government and agency obligations, mortgage- and asset-backed securities (including commercial mortgage-backed securities), corporate bonds, foreign bonds, and Treasury inflation protected securities.

Full PRXEX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PRXEX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PRXEX vs SCHDPRXEX vs JEPIPRXEX vs OPRXEX vs KOPRXEX vs MAINPRXEX vs ABBVPRXEX vs MRKPRXEX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.